Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. (ARNA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ARNA · as of Jun 8, 2026
Key Statistics
Explore Arena Pharmaceuticals, Inc. Data
arna stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 23 · Buy rate: 60.9%
The ARNA analyst consensus is Buy, based on ratings from 23 Wall Street analysts over the past 3 months. The average 12-month price target is $94.00, representing -5.99% downside from the current price of $99.99.
Competitors & Peers
arna competitorsARNA
ABCM
CERE
ISEE
MOR
MRTXStock Performance
Full HistoryAbout Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to developing innovative therapeutic agents, specifically designed with distinct pharmacological and pharmacokinetic profiles, for a g…
what is arena pharmaceuticals, inc. · arna stock overview · arena pharmaceuticals, inc. company profile · who is arena pharmaceuticals, inc. ceo · arna NASDAQ · arena pharmaceuticals, inc. headquarters · arena pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Arena Pharmaceuticals, Inc. (ARNA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 28, 2000. As of the latest trading session, ARNA stock price is $99.99, with a market capitalization of $0. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
According to 23 Wall Street analysts, the consensus rating for Arena Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $94.00. In fiscal year 2021, Arena Pharmaceuticals, Inc. reported revenue of $54000.00 and net income of -$620.6M. For detailed data — including Arena Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Arena Pharmaceuticals, Inc. (ARNA) stock price is $99.99. The stock is traded on NASDAQ under the ticker symbol ARNA. The 52-week range is $99.97 – $100.00.